Anna Devor.

Anna Devor

Professor of biomedical engineering
Boston University

Anna Devor is professor of biomedical engineering at Boston University (BU), associate director of the BU Neurophotonics Center, and editor-in-chief of the journal Neurophotonics, published by the optical engineering society SPIE.

Devor’s lab, the Neurovascular Imaging Laboratory, specializes in imaging neuronal, glial, vascular and metabolic activity in the brains of living and behaving experimental animals. Her research is focused on understanding fundamental neurovascular and neurometabolic principles of brain activity and the mechanistic underpinning of noninvasive brain imaging signals. She also works on imaging of stem-cell-derived human neuronal networks.

Devor received her Ph.D. in neuroscience from the Hebrew University of Jerusalem. After completing her postdoctoral training in neuroimaging at the Athinoula A. Martinos Center for Biomedical Imaging, she established her own lab at the University of California, San Diego before moving it to BU in 2020. She has a wide network of collaborators across the world and is experienced in leading large, multidisciplinary teams.

Explore more from The Transmitter

Novel assembloid illuminates serotonin changes linked to 22q11.2 deletion

The combination of a serotonin-producing organoid with an organoid based on the developing cerebral cortex offers a new way to investigate neuromodulation.

By Sarah DeWeerdt
30 April 2026 | 0 min watch
Conference attendees

Reporter’s notebook: Highlights from INSAR 2026

At the 25th annual meeting of the International Society for Autism Research, scientists, clinicians and self-advocates gathered to discuss topics such as autism genetics and the gap between clinical trials and real-world benefits.

By Diana Kwon
30 April 2026 | 6 min read
Illustration of hand with letter.

Scientists push back against stricter European Research Council grant application rules

In an open letter, scientists call the ERC’s suggestion to block grant reapplications for an additional year “at odds with scientific excellence.”

By Lauren Schenkman
29 April 2026 | 5 min read